| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 2114 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 2087 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 1493 | 2024 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 983 | 2022 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 849* | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 795 | 2024 |
| Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer S Reid, D Schindler, H Hanenberg, K Barker, S Hanks, R Kalb, ... Nature genetics 39 (2), 162-164, 2007 | 776 | 2007 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 WM Gardner, C Razo, TA McHugh, H Hagins, VM Vilchis-Tella, ... The Lancet Haematology 10 (9), e713-e734, 2023 | 581 | 2023 |
| Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study C Peters, JH Dalle, F Locatelli, U Poetschger, P Sedlacek, J Buechner, ... Journal of Clinical Oncology 39 (4), 295-307, 2021 | 350 | 2021 |
| Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases JF Li, YT Dai, H Lilljebjörn, SH Shen, BW Cui, L Bai, YF Liu, MX Qian, ... Proceedings of the National Academy of Sciences 115 (50), E11711-E11720, 2018 | 329 | 2018 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 257 | 2022 |
| Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment O Hrusak, T Kalina, J Wolf, A Balduzzi, M Provenzi, C Rizzari, S Rives, ... European Journal of Cancer 132, 11-16, 2020 | 238 | 2020 |
| Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the … A Haakenstad, JA Yearwood, N Fullman, C Bintz, K Bienhoff, MR Weaver, ... The Lancet global health 10 (12), e1715-e1743, 2022 | 193 | 2022 |
| An automated white blood cell nucleus localization and segmentation using image arithmetic and automatic threshold HT Madhloom, SA Kareem, H Ariffin, AA Zaidan, HO Alanazi, BB Zaidan Journal of Applied Sciences 10 (11), 959-966, 2010 | 189 | 2010 |
| Minimal residual disease–guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia … AEJ Yeoh, H Ariffin, ELL Chai, CSN Kwok, YH Chan, K Ponnudurai, ... Journal of clinical oncology 30 (19), 2384-2392, 2012 | 163 | 2012 |
| Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia H Ariffin, P Navaratnam, M Mohamed, A Arasu, WA Abdullah, CL Lee, ... International Journal of Infectious Diseases 4 (1), 21-25, 2000 | 155 | 2000 |
| Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP M Qian, H Zhang, SKY Kham, S Liu, C Jiang, X Zhao, Y Lu, C Goodings, ... Genome research 27 (2), 185-195, 2017 | 141 | 2017 |
| A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug l-asparaginase N Patel, S Krishnan, MN Offman, M Krol, CX Moss, C Leighton, ... The Journal of clinical investigation 119 (7), 1964-1973, 2009 | 140 | 2009 |
| Vincristine‐induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia CG Tay, VWM Lee, LC Ong, KJ Goh, H Ariffin, CY Fong Pediatric blood & cancer 64 (8), e26471, 2017 | 139 | 2017 |
| Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry T Moriyama, YL Yang, R Nishii, H Ariffin, C Liu, TN Lin, W Yang, DT Lin, ... Blood, The Journal of the American Society of Hematology 130 (10), 1209-1212, 2017 | 112 | 2017 |
Pierre HainautProfessor, Cancer Biology, University Grenoble Alpes and Director, Institute for AdvancedVerified email at univ-grenoble-alpes.fr
